As of 2025-03-19, the Relative Valuation of Reata Pharmaceuticals Inc (RETA) is (48.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 172.36 USD, the upside of Reata Pharmaceuticals Inc based on Relative Valuation is -128.0%.
The range of the Relative Valuation is (44.14) - (48.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 20.9x | 18.6x |
| Forward P/E multiples | 14.8x - 18.7x | 18.4x |
| Fair Price | (44.14) - (48.78) | (48.26) |
| Upside | -125.6% - -128.3% | -128.0% |
| Date | P/E |